Diabetes Care, Vol 20, Issue 5 785-791, Copyright © 1997 by American Diabetes Association

ARTICLES

Comparison of fasting and 2-hour glucose and HbA1c levels for diagnosing diabetes. Diagnostic criteria and performance revisited

MM Engelgau, TJ Thompson, WH Herman, JP Boyle, RE Aubert, SJ Kenny, A Badran, ES Sous and MA Ali
Division of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, GA 30341-3724, USA. mxe1@ccdddt1.cm.cdc.gov

OBJECTIVE: Nearly two decades ago, the National Diabetes Data Group (NDDG) and the World Health Organization (WHO) Expert Committee on Diabetes Mellitus published diagnostic criteria for diabetes. We undertook this study to compare the performance of three glycemic measures for diagnosing diabetes and to evaluate the performance of the WHO criteria. RESEARCH DESIGN AND METHODS: In a cross-sectional population-based sample of 1,018 Egyptians > or = 20 years of age, fasting and 2-h glucose and HbA1c levels were measured, and diabetic retinopathy was assessed by retinal photograph. Evidence for bimodal distributions was examined for each glycemic measure by fitting models for the mixture of two distributions using maximum likelihood estimates. Sensitivity and specificity for cutpoints of each glycemic measure were calculated by defining the true diabetes state (gold standard) as 1) the upper (diabetic) component of the fitted bimodal distribution for each glycemic measure, and 2) the presence of diabetic retinopathy. Receiver operating characteristic (ROC) curves were constructed to determine the performance of the glycemic measures in detecting diabetes as defined by diabetic retinopathy. RESULTS: In the total population, the point of intersection of the lower and upper components that minimized misclassification for the fasting and 2-h glucose and HbA1c were 7.2 mmol/l (129 mg/dl), 11.5 mmol/l (207 mg/dl), and 6.7%, respectively. When diabetic retinopathy was used to define diabetes, ROC curve analyses found that fasting and 2-h glucose values were superior to HbA1c (P < 0.01). The performance of a fasting glucose of 7.8 mmol/l (140 mg/dl) was similar to a 2-h glucose of 12.2-12.8 mmol/l (220-230 mg/dl), and the performance of a 11.1 mmol/l (200 mg/dl) 2-h glucose was similar to a fasting glucose of 6.9-7.2 mmol/l (125-130 mg/dl). CONCLUSIONS: Optimal cutpoints for defining diabetes differ according to how diabetes itself is defined. When diabetes is defined as the upper component of the bimodal population distribution, a fasting glucose level somewhat lower than the current WHO cutpoint and a 2-h glucose level somewhat higher than the current WHO cutpoint minimized misclassification. When diabetic retinopathy defines diabetes, we found that the current fasting diagnostic criterion favors specificity and the current 2-h criterion favors sensitivity. These results should prove valuable for defining the optimal tests and cutpoint values for diagnosing diabetes.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				V. R. Aroda and R. Ratner Approach to the Patient with Prediabetes J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3259 - 3265. [Abstract] [Full Text] [PDF]

				Y. Doi, M. Kubo, K. Yonemoto, T. Ninomiya, M. Iwase, H. Arima, J. Hata, Y. Tanizaki, M. Iida, and Y. Kiyohara Fasting Plasma Glucose Cutoff for Diagnosis of Diabetes in a Japanese Population J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3425 - 3429. [Abstract] [Full Text] [PDF]

				U.S. Preventive Services Task Force Screening for Type 2 Diabetes Mellitus in Adults: U.S. Preventive Services Task Force Recommendation Statement Ann Intern Med, June 3, 2008; 148(11): 846 - 854. [Abstract] [Full Text] [PDF]

				Z. T. Bloomgarden Screening for and managing diabetic retinopathy: Current approaches Am. J. Health Syst. Pharm., September 1, 2007; 64(17_Supplement_12): S8 - S14. [Abstract] [Full Text] [PDF]

				W. H. Herman Diabetes Epidemiology: Guiding Clinical and Public Health Practice: The Kelly West Award Lecture, 2006 Diabetes Care, July 1, 2007; 30(7): 1912 - 1919. [Full Text] [PDF]

				M. F. Crutchlow and R. D. Bloom Transplant-Associated Hyperglycemia: A New Look at an Old Problem Clin. J. Am. Soc. Nephrol., March 1, 2007; 2(2): 343 - 355. [Abstract] [Full Text] [PDF]

				P. Lucotti, E. Setola, L. D. Monti, E. Galluccio, S. Costa, E. P. Sandoli, I. Fermo, G. Rabaiotti, R. Gatti, and P. Piatti Beneficial effects of a long-term oral L-arginine treatment added to a hypocaloric diet and exercise training program in obese, insulin-resistant type 2 diabetic patients Am J Physiol Endocrinol Metab, November 1, 2006; 291(5): E906 - E912. [Abstract] [Full Text] [PDF]

				G. Brohall, C.-J. Behre, J. Hulthe, J. Wikstrand, and B. Fagerberg Prevalence of Diabetes and Impaired Glucose Tolerance in 64-Year-Old Swedish Women: Experiences of using repeated oral glucose tolerance tests Diabetes Care, February 1, 2006; 29(2): 363 - 367. [Abstract] [Full Text] [PDF]

				R. J. Heine, L. F. Van Gaal, D. Johns, M. J. Mihm, M. H. Widel, R. G. Brodows, and for the GWAA Study Group* Exenatide versus Insulin Glargine in Patients with Suboptimally Controlled Type 2 Diabetes: A Randomized Trial Ann Intern Med, October 18, 2005; 143(8): 559 - 569. [Abstract] [Full Text] [PDF]

				J. Fan, S. J. May, Y. Zhou, and E. Barrett-Connor Bimodality of 2-h Plasma Glucose Distributions in Whites: The Rancho Bernardo Study Diabetes Care, June 1, 2005; 28(6): 1451 - 1456. [Abstract] [Full Text] [PDF]

				D. S. Feig, V. A. Palda, L. Lipscombe, and with The Canadian Task Force on Preventive Health Screening for type 2 diabetes mellitus to prevent vascular complications: updated recommendations from the Canadian Task Force on Preventive Health Care Can. Med. Assoc. J., January 18, 2005; 172(2): 177 - 180. [Full Text] [PDF]

				A. M.W. Spijkerman, M. F. Yuyun, S. J. Griffin, J. M. Dekker, G. Nijpels, and N. J. Wareham The Performance of a Risk Score as a Screening Test for Undiagnosed Hyperglycemia in Ethnic Minority Groups: Data from the 1999 Health Survey for England Diabetes Care, January 1, 2004; 27(1): 116 - 122. [Abstract] [Full Text] [PDF]

				Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Diabetes Care, January 1, 2003; 26(90001): s5 - 20. [Full Text] [PDF]

				B. P. Tabaei and W. H. Herman A Multivariate Logistic Regression Equation to Screen for Diabetes : Development and validation Diabetes Care, November 1, 2002; 25(11): 1999 - 2003. [Abstract] [Full Text] [PDF]

				N. Charkoudian, A. Vella, A. S. Reed, C. T. Minson, P. Shah, R. A. Rizza, and M. J. Joyner Cutaneous vascular function during acute hyperglycemia in healthy young adults J Appl Physiol, October 1, 2002; 93(4): 1243 - 1250. [Abstract] [Full Text] [PDF]

				R G. Barr, D. M. Nathan, J. B. Meigs, and D. E. Singer Tests of Glycemia for the Diagnosis of Type 2 Diabetes Mellitus Ann Intern Med, August 20, 2002; 137(4): 263 - 272. [Abstract] [Full Text] [PDF]

				P.J. Park, S.J. Griffin, L. Sargeant, and N. J. Wareham The Performance of a Risk Score in Predicting Undiagnosed Hyperglycemia Diabetes Care, June 1, 2002; 25(6): 984 - 988. [Abstract] [Full Text] [PDF]

				Y. Bando, Y. Ushiogi, K. Okafuji, D. Toya, N. Tanaka, and M. Fujisawa The Relationship of Fasting Plasma Glucose Values and Other Variables to 2-h Postload Plasma Glucose in Japanese Subjects Diabetes Care, July 1, 2001; 24(7): 1156 - 1160. [Abstract] [Full Text] [PDF]

				J. Krakoff, R. L. Hanson, S. Kobes, and W. C. Knowler Comparison of the Effect of Plasma Glucose Concentrations on Microvascular Disease Between Pima Indian Youths and Adults Diabetes Care, June 1, 2001; 24(6): 1023 - 1028. [Abstract] [Full Text]

				L. A Sargeant, K.-T. Khaw, S. Bingham, N. E Day, R. N Luben, S. Oakes, A. Welch, and N. J Wareham Cigarette smoking and glycaemia: the EPIC-Norfolk Study Int. J. Epidemiol., June 1, 2001; 30(3): 547 - 554. [Abstract] [Full Text] [PDF]

				R. C. Perry, R. R. Shankar, N. Fineberg, J. McGill, and A. D. Baron HbA1c Measurement Improves the Detection of Type 2 Diabetes in High-Risk Individuals With Nondiagnostic Levels of Fasting Plasma Glucose: The Early Diabetes Intervention Program (EDIP) Diabetes Care, March 1, 2001; 24(3): 465 - 471. [Abstract] [Full Text]

				W. H. Herman and M. M. Engelgau Catch-22: A response to Davidson Diabetes Care, February 1, 2001; 24(2): 415 - 415. [Full Text]

				C. J. Greenbaum, D. Cuthbertson, and J. P. Krischer Type 1 Diabetes Manifested Solely by 2-h Oral Glucose Tolerance Test Criteria Diabetes, February 1, 2001; 50(2): 470 - 476. [Abstract] [Full Text]

				L. A. Hiltunen and S. M. Keinanen-Kiukaanniemi Effects of the WHO 1985 criteria and the proposed new diagnostic criteria on the prevalence of diabetes in an elderly population Scand J Public Health, October 1, 2000; 28(4): 266 - 269. [Abstract] [PDF]

				E. S Kilpatrick Glycated haemoglobin in the year 2000 J. Clin. Pathol., May 1, 2000; 53(5): 335 - 339. [Full Text] [PDF]

				R. C. Turner, C. A. Cull, V. Frighi, R. R. Holman, and for the UK Prospective Diabetes Study Group Glycemic Control With Diet, Sulfonylurea, Metformin, or Insulin in Patients With Type 2 Diabetes Mellitus: Progressive Requirement for Multiple Therapies (UKPDS 49) JAMA, June 2, 1999; 281(21): 2005 - 2012. [Abstract] [Full Text] [PDF]

				M. B. Davidson, D. L. Schriger, A. L. Peters, and B. Lorber Relationship Between Fasting Plasma Glucose and Glycosylated Hemoglobin: Potential for False-Positive Diagnoses of Type 2 Diabetes Using New Diagnostic Criteria JAMA, April 7, 1999; 281(13): 1203 - 1210. [Abstract] [Full Text] [PDF]

				J. Levy, R. Morris, M. Hammersley, and R. Turner Discrimination, adjusted correlation, and equivalence of imprecise tests: application to glucose tolerance Am J Physiol Endocrinol Metab, February 1, 1999; 276(2): E365 - E375. [Abstract] [Full Text] [PDF]

				DECODE Study Group, on behalf of the European Diab Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data BMJ, August 8, 1998; 317(7155): 371 - 375. [Abstract] [Full Text]

				H. Dean Diagnostic Criteria for Non-Insulin Dependent Diabetes in Youth (NIDDM-Y) Clinical Pediatrics, February 1, 1998; 37(2): 67 - 71. [Abstract] [PDF]